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TFF3-dependent resistance of human colorectal
adenocarcinoma cells HT-29/B6 to apoptosis is mediated
by miR-491-5p regulation of lncRNA PRINS
Carlos Hanisch1, Jutta Sharbati1,2, Barbara Kutz-Lohroff1, Otmar Huber3, Ralf Einspanier1 and Soroush Sharbati1
Tumour necrosis factor-α (TNF-α) is a double-edged cytokine associated with pathogenesis of inﬂammatory-related cancers being
also able to induce cancer cell death. In the process of tumour development or metastasis, cancer cells can become resistant to
TNF-α. In trefoil factor 3 (TFF3) overexpressing colorectal adenocarcinoma cells (HT-29/B6), we observed enhanced resistance
against TNF-α/interferon gamma-induced apoptosis. TFF3 is a secreted small peptide that supports intestinal tissue repair but is also
involved in intestinal tumour progression and scattering. We hypothesised that TFF3 rescues intestinal epithelial cancer cells from
TNF-α-induced apoptosis by involving regulatory RNA networks. In silico-based expression analysis revealed TFF3-mediated
regulation of selected microRNAs as well as long non-coding RNAs (lncRNAs), whereas miR-491-5p was identiﬁed to target the
lncRNA ‘psoriasis susceptibility-related RNA gene induced by stress’ (PRINS). RNA interference-based gain- and loss-of-function
experiments examined miR-491-PRINS axis to exert the TFF3-mediated phenotype. Chemical inhibition of selected pathways
showed that phosphatidylinositol 3-kinase/AKT accounts for TFF3-mediated downregulation of miR-491-5p and accumulation of
PRINS. Moreover, we showed that PRINS colocalises with PMAIP1 (NOXA) in nuclei of HT-29/B6 possessing inhibitory effects.
Immunoprecipitation experiments proved molecular interaction of PMAIP1 with PRINS. Our study provides an insight into RNA
regulatory networks that determine resistance of colorectal cancer cells to apoptosis.
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Impaired mucosal repair and consequently affected intestinal
homeostasis seem to be the cause for a variety of intestinal
diseases. Modulating effects on intestinal homeostasis and disease
have been reported for human trefoil factors (TFFs). So far, three
TFFs have been identiﬁed by the presence of so-called trefoil
factor domains. The intestinal trefoil factor (ITF or TFF3) is known
to act as a driving factor of intestinal epithelial repair.1 In a TNBS-
induced murine colitis model, TFF3 has been shown to decrease
tissue levels of tumour necrosis factor-α (TNF-α) suggesting a
therapeutic potential of TFF3 in inﬂammatory bowel disease.2
Accordingly, TFF3− /− mice have been shown to develop increased
intestinal apoptosis. By contrast, increased expression of TFF3 has
been also detected in tumours, where it appears to act as a potent
mitogen and inducer of epithelial migration associated with
tumour invasion, resistance to apoptosis and metastasis.3 Further-
more, it has been shown that TFF3 prevents TP53-dependent
apoptosis of gastrointestinal cancer cell lines in a phosphatidyli-
nositol 3-kinase (PI3K) dependent manner.4 Overexpression of
TFF3 signiﬁcantly inhibits IL-1β induction of TNF-α, this effect was
reversed after pre-treatment with the PI3K/AKT inhibitor
LY294002.5
The superfamily of TNF-proteins has pleiotropic effects.6 TNF-α-
related apoptosis-inducing ligand (TRAIL) activates the extrinsic
apoptosis pathway in a variety of tumour cells but not in normal
cells.7 Interferon gamma (IFN-γ) has a promising role in tumour
suppression by enhancing TRAIL-induced apoptosis.8 Moreover, a
combination of IFN-γ and TNF-α has been reported to markedly
sensitise metastatic colon carcinoma cells to TRAIL-induced
apoptosis.9 Increased TRAIL receptor expression along with
activation of the Wnt/β-catenin pathway has been associated
with aggravated survival of patients with colorectal carcinoma. At
the same time, increased β-catenin has been shown to gradually
increase TRAIL receptors.10 Interestingly, TFF3 activates AKT by
EGFR phosphorylation, which inhibits ubiquitination of β-catenin
and consequently causes its nuclear translocation to promote
proliferation of colorectal carcinoma cells.11 On a different note,
Shiah et al.12 have shown that non-coding RNAs (ncRNAs) regulate
the activator of Wnt/β-catenin signalling Wnt-7b. The tumour-
suppressing long non-coding RNA (lncRNA) MEG3 and microRNAs
(miRNAs) miR-329 and miR-410 have been reported to be
downregulated in oral squamous cell carcinoma resulting in
upregulation of Wnt-7b and β-catenin signalling.
Recent efforts in RNA biology have revealed that ncRNAs
control central cellular processes such as apoptosis in gastro-
intestinal malignancies.13 Only about 10% of human RNAs are
translated into functional proteins. The rest is classiﬁed into the
category of ncRNAs such as the well-characterised class of miRNA
or the rather heterogeneous class of lncRNAs. MiRNAs regulate
gene expression via degradation of mRNAs or inhibition of
translation taking part in central cellular processes.14 For example,
direct interaction of miR-491-5p with BCL2L1 has been reported to
induce apoptosis in colorectal cancer cells.15 Interestingly,
miR-491-5p transfected hepatoma-derived Huh7 cells have been
shown to suppress phosphorylation of AKT pointing to inhibition
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of PI3K-pathway.16 But also interactions between miRNAs and
lncRNAs have been described, prompting the idea of regulatory
networks of RNAs.17 Interactions between ncRNAs are suggested
to provide a plethora of unprecedented regulatory mechanisms
controlling development and disease. LncRNAs have been
reported to be involved in several steps of cancer development
as essential regulators, oncogenes or tumour suppressors.18,19
Along these lines, we have recently shown that the lncRNA MEG3
is a regulator of autophagy in macrophages.20 Another lncRNA,
psoriasis susceptibility-related RNA gene induced by stress (PRINS)
has been related to proliferation and differentiation states of
keratinocytes. Increased expression has been described in healthy
epidermis compared with psoriatic lesions.21 Silencing of PRINS by
RNA interference (RNAi) has revealed its protective role in
keratinocytes exposed to stress.22
TFFs are pro-invasive scatter factors interfering with PI3K/AKT,
EGFR and Wnt/β-catenin signalling.23 There is increasing evidence
that these pathways crosstalk in progression of cancer.24 In
addition, several studies point out the involvement of ncRNAs in
regulation of mentioned TFF-related pathways. Therefore, we
speculated that TFF3 exerts its protective effects on scattering
cancer cells via regulatory ncRNAs. To address this, we used TFF3-
overexpressing colorectal adenocarcinoma cells (HT-29/B6/TFF3)
as a model for scattering cancerous cells that are protected from
IFN-γ/TNF-α-induced apoptosis. We here show that the protective
phenotype is based on the interaction of miR-491-5p with the
lncRNA PRINS thereby regulating the availability of the pro-
apoptotic factor PMAIP1 (NOXA).
RESULTS
Increased TFF3 expression mediates resistance to IFN-γ/TNF-α-
induced apoptosis
To address our hypothesis, we applied a HT-29/B6 clone with
increased TFF3 expression (HT-29/B6/TFF3, Supplementary
Figure 1a) that has been shown to affect both the E-cadherin/
catenin complex and tight junction proteins, as well as mock-
transfected controls HT-29/B6/mock.25,26 Both produced highly
polarised epithelial monolayers without considerable phenotypic
differences (Supplementary Figure 1b). However, HT-29/B6/TFF3
exhibited slightly increased cell indices (xCELLigence) over 72 h
(Figure 1a). Treatment of both clones with TNF-α had no obvious
adverse effects on cell indices. But IFN-γ sensitisation followed by
TNF-α treatment caused a marked drop of cell index at 24 h in
mock-transfected controls and there was no signiﬁcant change in
cell index of HT-29/B6/TFF3 cells (Figure 1a). Subsequent
immunoﬂuorescence (IF) detection of active caspase-3(ref. 27) and
observation of fragmented and condensed nuclei proved induc-
tion of apoptosis after IFN-γ/TNF-α treatment only in HT-29/B6/
mock cells (Figure 1b).
TFF3 causes dysregulation of apoptosis-related ncRNAs
As TFF3-related pathways have been recently connected to RNA
regulatory mechanisms, we hypothesised that observed TFF3-
mediated resistance to apoptosis may be controlled by an
interplay of miRNAs and lncRNAs. To test this, we collected a set
of six miRNAs based on in silico analyses and literature search
(Supplementary Tables 1). The collection included three well-
known miRNAs (miR-16, miR-21 and miR-155) that have been
commonly related to apoptotic signalling and cancer,28–30 as well
as three underexplored miRNAs (miR-326, miR-329 and miR-491)
with accumulated targets in cancer and apoptotic pathways
(Supplementary Table 3). Based on our recent study,20 we selected
lncRNAs connected to the control of apoptosis (Supplementary
Table 4). Owing to the assumptions that (i) selected candidates
account for the protective phenotype of TFF3-overexpressing cells
and (ii) interactions between selected miRNAs and lncRNAs may
exist, these two sets of ncRNAs were examined for negative
correlation of expression. ncRNAs were examined in fully
differentiated HT-29/B6/TFF3- and mock-transfected cells on day
7 after seeding (Figures 1c and d). Expression data during the
process of differentiation on days 2 and 4 after seeding are shown
in Supplementary Figures 1c–f. Downregulation of several miRNAs
became apparent on day 7; miR-155, miR-326, miR-329 and
miR-491 exhibited clearly (≤0.67-fold changes) and signiﬁcantly
decreased expression (Po0.05) compared with mock controls
(Figure 1c and Supplementary Figures 1c and d). However, only
the lncRNA PRINS showed consistent and signiﬁcant upregulation
over the course of differentiation (Figure 1d and Supplementary
Figures 1e and f). Fully differentiated HT-29/B6/TFF3 exhibited
nearly double PRINS expression levels compared with mock
controls (Figure 1d, Po0.0001). Furthermore, PTENP1 and WT1
were signiﬁcantly upregulated, whereas NEAT1 showed decreased
expression (Figure 1d).
miR-491-5p regulates cellular availability of the lncRNA PRINS
Consequently, PRINS (HG975433.1) was tested for binding sites of
all four downregulated miRNAs using RNAhybrid.31 As shown in
Figure 1e, three miR-491-5p binding sites together with two
miR-329 sites and one miR-326 site were predicted
(Supplementary Figure 2). To verify predictions, we transfected
HT-29/B6/TFF3 with respective miRNA mimics, as well as nonsense
controls. Cellular PRINS levels were signiﬁcantly decreased
(Po0.05) only after miR-491-5p transfection (Figure 1f). Interac-
tion of miR-491-5p with predicted binding sites of PRINS was
proved by means of reporter gene assays. Only co-transfection of
the reporter plasmid containing binding site #3 and miR-491-5p
mimic resulted in a signiﬁcantly decreased luciferase activity
(Po0.01) and a reporter plasmid including the mutated site
proved the speciﬁcity of studied interaction (Figure 1g and
Supplementary Figure 3).
TFF3-dependent decrease of miR-491-5p confers PRINS-mediated
resistance to apoptosis
Treatment with IFN-γ/TNF-α as described above slightly enhanced
miR-491-5p expression in TFF3-overexpressing clones of HT-29/B6
cells (Figure 1h). This was accompanied with an opposite
regulation of PRINS in IFN-γ/TNF-α-treated HT-29/B6/TFF3 cells
compared with untreated controls, whereas PRINS levels of
treated HT-29/B6/mock remained at basal levels (Figure 1i).
Cytokine treatment had no effect on cellular transcript levels of
TFF3 in mock and TFF3-overexpressing clones (Figure 1j).
Small interfering RNA (siRNA) against PRINS (siPRINS) was used to
determine if PRINS has feedback regulatory effects on miR-491-5p.
Signiﬁcant knockdown of PRINS in HT-29/B6/TFF3 (Po0.001) did not
affect cellular miR-491-5p levels (Supplementary Figures 4a and b).
Next, we asked if decreased miR-491-5p and consequently
increased PRINS levels are the reason for protective effects of TFF3
against IFN-γ/TNF-α-induced apoptosis in HT-29/B6. We con-
ducted gain-of-function experiment using miR-491-5p mimics
and loss-of-function experiments using siPRINS. After transfection,
HT-29/B6 clones were treated with IFN-γ/TNF-α or remained
untreated and apoptosis was examined by detection of active
caspase-3 via IF (Figure 2a). Mocks either transfected with miR-491-5p
or siPRINS exhibited a signiﬁcant increase (PmiR-491o0.05 and
PsiPRINSo0.01) of apoptotic cells (Figures 2a and b, Supplementary
Figure 5). Exposure of HT-29/B6/mock to IFN-γ/TNF-α caused more
than threefold, and signiﬁcant (Po0.01) increase of apoptotic
cells independent of treatment with nonsense, miR-491 or siPRINS
(Figures 2a and b, Supplementary Figure 5). As observed before,
nonsense-transfected HT-29/B6/TFF3 cells were protected against
IFN-γ/TNF-α-induced apoptosis. But miR-491-5p transfection, as
well as siPRINS along with IFN-γ/TNF-α stimulation caused a
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Figure 1. TFF3 overexpression in HT-29/B6 confers resistance to TNF-α/IFN-γ-induced apoptosis concomitant with dysregulation of apoptosis-
related ncRNA. (a) Cell indices of HT-29/B6/TFF3 and mock-transfected colorectal adenocarcinoma cells were determined using xCELLigence
analyses over 72 h. Bars show S.D. of at least four replicates. TFF3-overexpressing cells were protected from TNF-α/IFN-γ-induced apoptosis.
(b) Apoptosis was evaluated by IF detection of active caspase-3. White arrows indicate apoptotic cells that are positive for active caspase-3
and have fragmented nuclei. Scale bars indicate 25 nm. (c) Expression of miRNAs was determined at day 7 after seeding. White columns show
mock controls and black TFF3-overexpressing HT-29/B6 cells. Error bars indicate the S.D. Values were log2 transformed. (d) Expression of
lncRNAs was determined at day 7 after seeding. White columns show mock controls and black TFF3-overexpressing HT-29/B6. Error bars
indicate the S.D. Values were log2 transformed. (e) Multiple binding sites for miR-326, miR-329 and miR-491-5p were identiﬁed in the PRINS
sequence (HG975433). (f) HT-29/B6/TFF3 were transfected with miR-326, miR-329, miR-491-5p (hatched columns) or nonsense (ns) controls
(white column) and expression of PRINS was compared with ns-transfected mock (black column) 24 h post treatment. Error bars indicate the
S.D. Values were log2 transformed. (g) Luciferase reporter gene assays identiﬁed miR-491-5p to target binding site (bs) #3. The mutated site
(bs #3 m) served as a control. Samples were taken at 24 h after transfection. Black columns show ns-transfected controls. Error bars indicate
the S.D. Values were log2 transformed. (h–j) Bar diagrams show the expression of miR-491-5p, PRINS and TFF3 in TNF-α/IFN-γ-treated
(+) HT-29/B6/TFF3 (dotted) and mock cells (squares) compared with untreated mock controls (black) and HT-29/B6/TFF3 (white). Error bars
indicate the S.D. Values were log2 transformed. Columns show means of at least three biological replicates and bars indicate S.D. *Po0.05;
**Po0.01; ***Po0.001; ****Po0.0001, unpaired t-test.
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marked increase (46-fold, Po0.0001) of apoptotic cells
(Figures 2a and c).
Following the same treatment regime, we also examined cell indices.
The xCELLigence data (Figure 2d) were baseline corrected using
untreated nonsense-transfected HT-29/B6/mock (cell indexsample/
cell indexmock nonsense untreated). Cytokine treatment caused reduction
of cell index of mock cells without obvious differences among
transfections. In general, cell indices of TFF3-overexpressing
clones decreased after siPRINS and even more after miR-491-5p
transfection compared with nonsense-transfected controls
Figure 2. miR-491-5p-mediated PRINS regulation controls apoptosis of colorectal adenocarcinoma cells. (a) Apoptosis of miR-491-5p or
siPRINS-transfected along with TNF-α/IFN-γ treatment was evaluated by IF detection of active caspase-3. Scale bars indicate 25 nm. Upper
right section shows micrographs at higher magniﬁcation. Scale bars indicate 50 nm. (b and c) The number of apoptotic cells (positive for
active caspase-3) was quantiﬁed using ImageJ considering at least four sections of three biological replicates of each treatment. Black columns
show untreated mock controls and columns with squares mocks treated with TNF-α/IFN-γ. White columns show untreated HT-29/B6/TFF3 cells
and dotted columns HT-29/B6/TFF3 cells treated with TNF-α/IFN-γ (+). Error bars indicate the S.D. (d) Cell indices of HT-29/B6/TFF3- and
mock-transfected cells were determined after miR-491-5p or siPRINS transfection along with TNF-α/IFN-γ treatment by means of
xCELLigence analysis over 36 h. Nonsense-transfected mock controls were selected as baseline and data were baseline corrected (cell
indexsample/cell indexmock nonsense untreated). Bars show S.D. of at least four replicates. Values were log2 transformed. Columns show means of at
least three biological replicates and bars indicate S.D. *Po0.05; **Po0.01; ***Po0.001; ****Po0.0001, unpaired t-test.
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(Figure 2d). In these cells, IFN-γ/TNF-α treatment along with
miR-491-5p transfection caused signiﬁcantly reduced cell indices
(Po0.001) at 36 h compared with transfected but untreated
controls (Figure 2d).
miR-491-5p-mediated regulation of PRINS depends on PI3K/AKT
We used small molecule inhibitors (SMI) to examine signalling
pathways that exert miR-491-5p inhibitory effect of TFF3. Applied
SMIs are known to inhibit TFF3-relevant pathways (JAK2, PAR1,
β-catenin and PI3K). As shown in Figure 3a, inhibition of PI3K/AKT
by LY294002 resulted in increased miR-491-5p expression as early
as 1.5 h after treatment. At 3 h, miR-491-5p level was more than
twofold and signiﬁcantly increased (Po0.05) compared with
control-treated HT-29/B6/TFF3. Western blotting revealed efﬁcient
inhibition of AKT after LY294002 treatment of HT-29/B6/TFF3
without effects on PDK1 (Ser241) phosphorylation (Figures 3b
and c). Chemical PI3K/AKT inhibition and consequently increased
miR-491-5p efﬁciently reduced cellular PRINS levels compared
with untreated HT-29/B6/TFF3 cells without effects on TFF3
expression (Figure 3d). To determine whether miR-491-5p
regulation of PRINS had feedback effects on PI3K/AKT signalling,
we examined activation states of downstream kinases after RNAi
(siPRINS and miR-491 mimic). RNAi had no obvious effect on
phosphorylation status of AKT and PDK1. p70-S6K Thr389
phosphorylation was diminished in HT-29/B6/mock compared
with TFF3-overexpressing cells (Figures 3e and f). SiPRINS as
well as miR-491-5p enhanced phosphorylation of p70-S6K Ser371
in mock cells compared with nonsense-transfected controls
(Figures 3e and f).
PRINS interacts with PMAIP1 (NOXA) in nuclei of HT-29/B6/TFF3
cells and determines its availability
It has been recently shown that FOXK2-dependent induction of
apoptosis results in unexpectedly increased phosphorylation of
p70-S6K, as well as upregulation of pro-apoptotic genes such as
PMAIP1 (NOXA).32 We used an RT-qPCR array comprising genes
relevant to apoptosis33 and evaluated the effect of miR-491-5p
mimics, as well as siPRINS. TFF3 overexpression caused increased
cellular BCL2 and BBC3 levels. The pro-apoptotic factor PMAIP1
(NOXA), death receptor TNFRSF6 (FAS), growth factor-related
phospholipase PLCG2, as well as BIRC3 were signiﬁcantly down-
regulated in nonsense-transfected HT-29/B6/TFF3 cells (Figure 4a).
Transfection of HT-29/B6/TFF3 cells with miR-491-5p mimic
compensated for BCL2, BBC3, PLCG2 and PMAIP1 dysregulation
(Figure 4b). However, treatment of HT-29/B6/TFF3 cells with
siPRINS shifted only PLCG2 and PMAIP1 expression to mock levels
suggesting functional coherence to PRINS (Figure 4c).
Consequently, we focused on PMAIP1 as a prominent pro-
apoptotic factor. We ﬁrst determined cellular localisation of PRINS
and PMAIP1 in HT-29/B6/TFF3 cells. Using Stellaris RNA ﬂuores-
cence in situ hybridisation (FISH) probes, PRINS was exclusively
detected in nuclei (Figure 4d). In most cells, only few foci per
nucleus were detected. Negative controls proved the speciﬁcity of
Figure 3. Decreased levels of miR-491-5p in TFF3-overexpressing
HT-29/B6 cells depend on PI3K-AKT activation. (a) SMIs for relevant
pathways (JAK2, PAR1, β-catenin and PI3K) were used to test
for compensation of miR-491-5p dysregulation in HT-29/B6/TFF3
cells. White columns represent controls and hatched columns
treated cells. Bars indicate the S.D. Values were log2 transformed.
(b) Western blotting proved the functionality of the PI3K inhibitor in
HT-29/B6/TFF3 cells. Black borders indicate cropped area of the
western blot. Molecular weights (MWs) were determined with
the Fusion Capt Advance Software (Vilber Lourmat) according to the
MW marker Page Ruler Plus Prestained Protein Ladder (Thermo
Fisher Scientiﬁc GmbH). (c) Densitometric analysis of b signals was
performed using the Fusion Capt Advance Software (Vilber Lourmat,
Eberhardzell, Germany). Columns show normalised means (protein
of interest/GAPDH) of three independent replicates and bars
represent the S.D. Values were log2 transformed. (d) PI3K inhibition
decreased cellular levels of PRINS and had no effect on TFF3 levels.
Values were log2 transformed. (e) Western blot detection of
phosphorylation status of AKT, PDK1 and p70-S6K upon miR-491-
5p or siPRINS transfection were determined. Black borders indicate
cropped area of the western blot. MWs were determined with the
Fusion Capt Advance Software (Vilber Lourmat) according to the
MW marker Page Ruler Plus Prestained Protein Ladder (Thermo
Fisher Scientiﬁc GmbH). (f) Densitometric analysis of section e was
performed using the Fusion Capt Advance Software (Vilber
Lourmat). Columns show normalised means (protein of interest/
GAPDH) of three independent replicates and bars represent the S.D.
Values were log2 transformed.
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Figure 4. PRINS interacts with PMAIP1 and determines its availability. (a–c) Volcano plots show signiﬁcantly dysregulated apoptosis-relevant
genes in nonsense, miR-491-5p or siPRINS-transfected HT-29/B6/TFF3 cells compared with nonsense-transfected mock controls (green:
signiﬁcantly downregulated; red: signiﬁcantly upregulated). (d) PRINS localisation was determined by Stellaris FISH, arrows show focal PRINS
signals (red: PRINS, blue: DAPI, scale bars indicate 25 nm). (e) PMAIP1 localisation was determined by IF (green: PMAIP1, yellow: f-actin, blue:
DAPI, scale bars indicate 25 nm). (f) Colocalisation of PRINS with PMAIP1 was determined by combination of FISH and IF (red: PRINS, green:
PMAIP1, blue: DAPI, scale bars indicate 25 nm). (g and h) Co-IP using the PMAIP1-speciﬁc antibody (CST, #D8L7U), experiments show speciﬁc
interaction of PRINS with PMAIP1 proved by PCR (pulldown sample). Lysate supernatant (sn) and diverse washes were taken as controls.
GAPDH serves as control for assay speciﬁcity. (i) PRINS knockdown in HT-29/B6/TFF3 cells causes accumulation of PMAIP1 with no differences
in FOXK1 and 2. Black borders indicate cropped area of the western blot. MWs were determined with the Fusion Capt Advance Software
(Vilber Lourmat) according to the MW marker Page Ruler Plus Prestained Protein Ladder (Thermo Fisher Scientiﬁc GmbH). (j) Densitometric
analysis of section i was performed using the Fusion Capt Advance Software (Vilber Lourmat). Columns show normalised means (protein of
interest/GAPDH) of three independent replicates and bars represent the S.D. Values were log2 transformed.
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signals (Supplementary Figures 6a and b). Cellular distribution of
PMAIP1 in TFF3-overexpressing cells was investigated by means
of IF. Similar to PRINS, a small number of accumulated signals per
nucleus were detected (Figure 4e). Colocalisation studies revealed
perfectly matching focal ﬂuorescence signals of PRINS and PMAIP1
in nuclei (Figure 4f). As FOXK2 has been recently related to
PMAIP1, we also examined colocalisation of PRINS with FOXK1 and
FOXK2. However, no spatial coherence between PRINS and FOXK
proteins was observed (Supplementary Figures 6c–f). Colocalisa-
tion of PRINS and PMAIP1 prompted their molecular interaction,
which was addressed by co-immunoprecipitation (co-IP) of PRINS
after pulldown of PMAIP1. As shown in Figure 4g, PRINS was
detected in lysates used for co-IP. Wash steps with increased
stringency resulted in successively decreased detection of PRINS.
In RNA samples isolated from supernatants of the ﬁnal wash PRINS
was no longer detectable (Figure 4g, wash IV). However, in RNA
samples extracted after release of PMAIP1 from beads, PRINS was
still detectable, pointing to protection from RNase digestion by
speciﬁc binding either directly to PMAIP1 or to ribnucleoprotein
complexes including PMAIP1 (Figure 4g, pulldown). GAPDH served
as a control for co-IP and disappeared fully after RNase digestion
(Figure 4h). Another control for speciﬁcity of co-IP was considered
by replacing the PMAIP1-speciﬁc antibody with normal rabbit IgG.
PRINS detection was decreased with enhanced washing and no
PRINS was detected in pulldown samples (Supplementary
Figure 6g). Furthermore, we addressed regulatory effects of PRINS
on PMAIP1. For this purpose, we transfected HT-29/B6/TFF3 cells
with siPRINS and studied PMAIP1 (NOXA) levels by western
blotting. As shown in Figures 4i and j, PRINS knockdown clearly
enhanced cellular PMAIP1 levels in TFF3-overexpressing cells
compared with nonsense-transfected controls. PRINS knockdown
had no obvious effects on FOXK1 and 2 expression levels
(Figure 4i).
DISCUSSION
Restitution of intestinal tissue and maintenance of homeostasis
requires migration of intact cells at the site of injury. TFF3 seems
to take a key role in this process not only as a potent mitogen but
also by inhibiting apoptosis when epithelial cells lose their
integrity to migrate to the site of injury. However, pathologic
TFF3 expression exerts similar effects in different cancers and
promotes metastatic seeding.25,34 Human intestinal adenocarci-
noma cells HT-29/B6 used in this study grow as polarised
monolayers and represent a well-established in vitro model for
intestinal cell biology.35 Several studies suggested a close
connection of TFF3 to PI3K/AKT and Wnt pathways, both
commonly reported to be dysregulated in cancer. But so far little
is known about the molecular mode of TFF3 action. Although the
role of PI3K/AKT in metastatic colon cancer has been recognised
long ago, it became recently apparent that ncRNAs are potent
regulators in this context.36 The importance of ncRNAs is
demonstrated by the fact that a substantial part of genome is
devoted to their transcription. In this context, RNA–RNA interac-
tions have been shown to regulate wide-ranging cellular
processes. As the power of miRNA in regulation of mRNA has
been explored elaborately, we are beginning to recognise the
complex interactions of miRNAs and lncRNAs and ensuing RNA
regulatory networks. Interaction of miRNAs with lncRNAs is an
emerging scientiﬁc ﬁeld helping to disclose missing links in basal
cellular regulation helping to provide novel therapeutic strategies
in diverse diseases. We considered TFF3-mediated resistance to
apoptosis in colorectal adenocarcinoma cells as a basis for
exploring RNA regulatory networks that confer the observed
apoptosis-resistant phenotype.
Consequently, we considered ncRNAs based on our earlier
studies, literature searches and in silico analyses. To test for
interactions between miRNAs and lncRNAs, contrary expression
was examined. Expression analyses were performed along the
course of differentiation on days 2, 4 and 7 after seeding. As TFF3
is constitutively overexpressed in HT-29/B6 cells, we hypothesised
that potential RNA regulatory networks that exert TFF3 effects
exist regardless of the differentiation state. Therefore, we focused
primarily on candidates that showed opposing expression
throughout differentiation period. We concentrated on miR-155,
miR-326, miR-329 and miR-491-5p showing stable downregulation
after prolonged incubation. PRINS was the only lncRNA fulﬁlling
the criterion of contrary expression with respect to dysregulated
miRNAs and the criterion of possessing a stable dysregulation.
However, the expression kinetics indicated that regulation of
PRINS cannot solely be attributed to TFF3. This suggests the
assumption that differentiation state of cells may have an
inﬂuence on the expression of relevant genes and justiﬁes the
4-day pre-incubation of HT-29/B6 subclones in experiments. Our
results show that only miR-491-5p signiﬁcantly regulates PRINS.
After transfection with miR-326 mimic, we recorded a trend in
PRINS downregulation. Nevertheless, regulation of PRINS by
miR-326 may be anticipated. Splicing variants and alternative
tertiary structures of PRINS may appear in a differentiation-
dependent manner, which could be under the control of miRNAs
other than miR-491-5p. Future studies are needed to disclose
alternative PRINS architecture.
Our results show that TFF3 inhibits miR-491-5p expression in
HT-29/B6 cells thus reducing cellular levels of PRINS. As miR-491-
5p has been reported to be a pro-apoptotic molecule,37,38 we
assumed that protective effects of TFF3 rely on miR-491-5p-
dependent accumulation of PRINS. Interestingly, 3 h after cytokine
stimulation miR-491-5p tended to be increased in HT-29/B6/TFF3
cells. On the contrary, PRINS expression signiﬁcantly decreased in
HT-29/B6/TFF3 cells, whereas expression levels remained
unchanged in HT-29/B6/mock-transfected cells. PRINS expression
in HT-29/B6/mock cells is presumably at a consistently low basal
level, so that a further decrease is not anticipated. Cytokine
stimulation inﬂuenced the observed miR-491-5p-PRINS axis.
Moreover, gain-of-function as well as loss-of-function experiments
pushed HT-29/B6/TFF3 phenotype toward mock controls proving
that the observed protective effects of TFF3 rely on the mentioned
axis. MiR-491-5p has been reported to efﬁciently induce apoptosis
in ovarian carcinoma by targeting BCL2L1 and accumulating
BCL2L11 in its dephosphorylated form.37 In pancreatic cancer,
miR-491-5p expression was decreased compared with normal
tissue. It has been shown to target BCL2L1 and TP53, in
consequence cancer cell proliferation was decreased with
increased doses of miR-491-5p.38 As mentioned above, disease-
related regulation of apoptotic protein-coding transcripts via
miRNAs is a well-recognised fact. Here, we show that miRNA-
mediated regulation of lncRNAs such as PRINS constitutes a
further level of regulation of apoptosis in colorectal cancer cells.
A class of lncRNAs has been deﬁned as competing endogenous
RNAs that vie for miRNA-binding sites with a protein-coding target
thus functioning as a miRNA sponge.39 In our study, TFF3-
dependent downregulation of miR-491-5p caused accumulation
of PRINS. However, speciﬁc knockdown of PRINS had no effects on
miR-491-5p levels. Therefore, it is unlikely that PRINS functions as a
miRNA sponge.
TFF3-deﬁcient mice have been reported to exhibit increased
colonocyte apoptosis and exogenous TFF3 has been shown to
protect from apoptosis. The anti-apoptotic effects of TFF3 have
been related to PI3K signalling and TP53 inhibition.4 In miR-491-5p
mimics- as well as siPRINS-experiments, we showed that HT-29/
B6/TFF3 cells became more susceptible to apoptosis. Unexpect-
edly, both treatments caused increased phosphorylation of p70-
S6K in HT-29/B6/mock cells. In a recent study, it has been shown
that knockdown of FOXK2 impaired proliferation and induced
apoptosis. In accordance with our observations, induction of
apoptosis was accompanied by unexpectedly increased
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phosphorylation of p70-S6K. The authors have speculated that
enhanced p70-S6K phosphorylation in apoptotic cells may
represent a compensatory mechanism. At the same time, they
reported that absence of FOXK2 leads to upregulation of pro-
apoptotic PMAIP1.32 Consequently, we screened for protein-
coding transcripts that are relevant to apoptotic signalling33 and
are compensated upon restoring miR-491-5p deﬁciency, as well as
PRINS excess. Thereby identiﬁed PLCG2 and PMAIP1 are
apparently controlled by the examined miR-491-5p-PRINS axis.
PLCG2 takes part in protein kinase C (PKC) signalling and has been
shown to cause nuclear translocation of PKCα during the
induction of apoptosis in gastric cancer cells.40 Our localisation
studies showed that PRINS and PMAIP1 (NOXA) exhibit focal and
overlapped ﬂuorescence signals in the nucleus prompting their
functional interaction, which we proved by co-IP experiments.
Among others, lncRNAs have been described to function as
scaffolds that bring together different proteins to build ribonu-
cleoprotein complexes.41 Our data point out that PRINS interacts
either directly or presumably via involved ribonucleoprotein
complexes with PMAIP1 in the nucleus. We also showed that
PRINS knockdown resulted in PMAIP1 accumulation. PMAIP1 is
known to recruit MCL1 from the cytosol to the mitochondria
causing its degradation.42 Colorectal tumours have been
described to show both nuclear and cytoplasmic expression of
PMAIP1.43 However, its function in the nucleus is not yet known.
We assume that PRINS functions as a scaffold that ascertains
nuclear localisation of PMAIP1 retaining its apoptotic action in the
cytoplasm/mitochondria.
In conclusion, TFF3 exerts its anti-apoptotic effects by means of
AKT/PI3K-dependent miR-491-5p downregulation and increased
levels of PRINS in HT-29/B6 cells. PRINS interacts with PMAIP1 in
the nucleus and presumably prevents its pro-apoptotic action in
the cytoplasm. Our ﬁndings will help to gain knowledge about the
molecular mechanisms behind resistance of cancer cells to
apoptosis and show that RNAi-based approaches may contribute
to the development of more effective TRAIL-based cancer
therapies as explored in colorectal adenocarcinoma cells.
MATERIALS AND METHODS
Cell culture, xCELLigence, chemical treatment and nucleofection
The subclone HT-29/B6 (ref. 44) of the human colorectal adenocarcinoma
cell line HT-29 (ACC299), and its stably transfected clones HT-29/B6/TFF3
and HT-29/B6/mock25 were maintained in RPMI supplemented with 10%
(v/v) FCS superior (Biochrom, Berlin, Germany) and 400 μg/ml G418 (Carl
Roth, Karlsruhe, Germany)—for stably transfected clones—at 37 °C and 5%
CO2 in 75 cm
2
ﬂasks (Sarstedt, Nümbrecht, Germany). HeLa cells (ATCC,
Wesel, Germany, CCL-2) were cultured in RPMI supplemented with 10% (v/
v) FCS superior, gentamicin (Biochrom) and L-glutamine (Biochrom). Cells
were passaged when reached 70–90% conﬂuence.
The xCELLigence (ACEA Biosciences, San Diego, CA, USA) system was
used according to the instructions of the supplier. Cells were seeded at a
density of 1.5 × 104 per well in a gold cell sensor incorporated E-plate.
Physiological changes of cells were analysed by the electronic impedance,
which is represented by the unit-less cell index. Cell index was monitored
every 15 min for a period of up to 7 days after treatment. Four days after
incubation, cells were sensitised using 40 ng/ml IFN-γ (CST, Frankfurt,
Germany) for 15 min. After removing the media, cells were treated with
100 ng/ml TNF-α (Sigma Aldrich, Taufkirchen, Germany). Untreated
controls were considered. Cell indexes were normalised immediately after
treatment.
For SMI experiments, cells were treated 4 days after seeding with 50 μM
AG490, 1 μM SCH7979, 50 μM iCRT14, 20 μM LY294002 (all provided by
Tocris Bioscience, Wiesbaden, Germany), respectively. Samples were taken
at 1.5 and 3 h after treatment.
HT-29/B6 derivatives were transfected using the Nucleofector Technol-
ogy (Lonza AG, Köln, Germany). For nucelofection, 1 × 106 cells were used
together with 50 pmol of miRVana miRNA mimics (Life Technologies,
Darmstadt, Germany), 100 pmol siRNA versus PRINS (5′-UUUCUGG
AAUGAUGUCCAA-3′, Euroﬁns Genomics, Ebersberg, Germany) or
50–100 pmol nonsense control RNA (Thermo Fisher Scientiﬁc GmbH,
Darmstadt, Germany), respectively. Twenty-four hours after transfection,
cells were washed with PBS and lysed for RNA or protein isolation.
RNA isolation and RT-qPCR
For expression analysis, 5 × 105 cells per well were plated and grown on
six-well plates (Sarstedt) for 4 days or taken after 24 h after nucleofection.
Total RNA was isolated with miRVana Isolation Kit (Life Technologies) and
quality controlled as described earlier.45 MiRNA as well as lncRNA-speciﬁc
RT-qPCR was performed as described previously20,45,46 considering
SNORD44 and 47 as references for miRNA and GAPDH, SDHA and
SNORD47 for lncRNA, respectively.
Dual luciferase reporter assays
To analyse the interaction between miR-491-5p and predicted binding
sites in PRINS (HG975433), dual luciferase reporter assays (Gaussia/
Cypridina NEB, Frankfurt, Germany) were performed using the vectors
pTKGluc and pTKCluc (NEB) together with synthetic binding sites
(Supplementary Figure 2) as described previously.47 For transfection,
1 μg of pTKGluc derivatives, 100 ng pTKCluc (for normalisation) and
100 pmol miRNA mimic were used.
IF detection and western blot
Cells were seeded (5 × 104 cells per well) on eight-well tissue culture
chamber slides (Sarstedt). After attachment, monolayers were treated with
40 ng/ml IFN-γ for 15 min, washed with PBS and exposed to 100 ng/ml
TNF-α or remained untreated as controls. Twenty-four hours after
treatment, cells were washed with PBS and IF of active caspase-3 was
performed as described earlier27 and signals were detected using the
microscope DMI6000 B (Leica, Wetzlar, Germany). At least four randomly
selected sections were taken for semi-automatic cell counting with
ImageJ.48 Numbers of DAPI-stained nuclei and active caspase-3-positive
cells were used to calculate the percentage of apoptotic cells. At least three
biological replicates were considered. FOXK1, 2 or PMAIP1 (NOXA) were
detected by means of IF using anti-FOXK1 (1 : 400, CST #12025), anti-
FOXK2 (1 : 400, CST #12008) or anti-NOXA (1 : 400, CST, #D8L7U) diluted in
1% BSA in PBS.
Western blotting was performed as described earlier20,49 using following
antibodies and dilutions: GAPDH, 1 : 2000 (CST # D16H11); pho-AKT,
1 : 2000 (Ser473, CST #D9E); pan-AKT, 1 : 1000 (CST #C67E7); pho-PDK1,
1 : 1000 (Ser241, CST #C49H2); pan-P70-S6K, 1 : 1000 (CST #49D7), pho-
P70-S6K, 1 : 1000 (Ser371, CST #9208); pho-P70-S6K, 1 : 2000 (Thr389, CST
#108D2); NOXA, 1: 750 (CST, #D8L7U), FOXK1, 1 : 1000 (CST #12025);
FOXK2, 1 : 1000 (CST #12008). HRP-labelled anti-rabbit IgG (CST #7074P2)
was used at a concentration of 1 : 2000.
Fluorescence in situ hybridisation
In all, 5 × 104 cells per well of an eight-well chamber slide (Sarstedt) were
seeded incubated for 4 days. PRINS localisation in HT-29/B6 and its
subclones were performed by means of custom Stellaris RNA FISH System
(Biosearch Technologies, Petaluma, CA, USA) according to the manufac-
turers protocol. For this purpose, 35 PRINS-speciﬁc probes were used
which were tagged with CAL Fluor Red 610 (Supplementary Table 5).
Combined FISH and IF for RNA-protein colocalisation studies
Cells were seeded as described above. After removing media, cells were
washed with PBS and ﬁxed with 3.7% formaldehyde at room temperature
for 10 min. Monolayers were washed twice with PBS for 5 min and
permeabilised using 0.1% (v/v) Tween 100 and 1% (w/v) BSA in PBS for
30 min. Cells were incubated with the primary antibody (diluted in PBS
with 1% (w/v) BSA) either for 1 h at room temperature or overnight at 4 °C.
After washing twice with PBS for 5 min, the secondary antibody anti-rabbit
488 (Thermo Fisher Scientiﬁc GmbH (#35552) goat anti-rabbit IgG (H+L)
Dylight 488 conjugated) was applied using a dilution of 1 : 200 in in PBS
with 1% (w/v) BSA. Cells were washed twice with wash buffer from Stellaris
RNA FISH System (Biosearch Technologies). Hybridisation and detection of
PRINS was performed as described above. Nuclei were detected using
0.5 μg/ml DAPI for 4 min and F-actin was detected using 2.5 U/ml
phalloidin (Atto 647N #65906, Sigma Aldrich) for 20 min.
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Immunoprecipitation and RNA pulldown
Immunoprecipitation was performed as described earlier47 with following
modiﬁcations. To address PRINS interaction with PMAIP1, 8 × 106 HT-29/B6/
TFF3 cells were seeded in 75 cm2 ﬂasks and incubated for 4 days. After
washing three times with PBS, monolayers were lysed using 750 μl of cell
lysis buffer (CST) supplemented with 1 mM PMSF (Sigma Aldrich). After
5-min incubation on ice, cells were scraped off and lysates were transferred
into a tube for three rounds of sonication using a Branson Soniﬁer 250 (5 s,
constant duty cycle, output control 1). The lysate was centrifuged for 10 min
at 14 000×g and the supernatant was precleared using 40 μl Protein G
Magnetic Beads (NEB). For this purpose, 200 μl of lysate was incubated with
prewashed (Cell Lysis Buffer, CST) magnetic beads for 2 h at 4 °C and gentle
rotation. The precleared lysate was incubated overnight at 4 °C with anti-
PMAIP1 antibody (CST, #D8L7U) using a 1 : 100 dilution. PMAIP1 was
immunoprecipitated for 4 h at 4 °C using 40 μl of prewashed magnetic
beads. The supernatant was taken as a control sample (Figure 4i, lysate sn.).
To remove unspeciﬁcally binding RNA, bead-bound ribonucleoprotein
complexes were prone to RNase A digestion for 1 h at 37 °C using 20 ng/
ml RNase A and RNase-buffer (50 mM Tris-HCl, 10 mM EDTA, pH 8). Digested
RNAs that were not bound to protein were removed by means of four
successive washes of beads with increasing stringency at room temperature
and with gentle rotation. Wash I: 5 min using cell lysis buffer (CST). Wash II
and III: 5 min using Stellaris Wash Buffer A. Wash IV: 5 min using Stellaris
Wash Buffer B. The supernatants were kept as controls (Figure 4i, Washes I–
IV). After washing steps, complexes bound to the beads were resuspended
in cell lysis buffer (CST) and treated with 200 μg/ml proteinase K for 30 min
at 37 °C to dissociate speciﬁcally protein-bound RNAs that were protected
from RNase A digestion. Released nucleic acids were precipitated by ethanol
and the pellet was resolved in 300 μl miRVana lysis buffer to extract the RNA
with the miRVana Isolation kit (Life Technologies). Isolated RNA was reverse
transcribed and PMAIP1-bound PRINS was detected as described above.
GAPDH mRNA was considered as a soluble and not PMAIP1 associated
control. For proving the speciﬁcity of the assay, the PMAIP1-speciﬁc
antibody was replaced with same amounts (1.1 μg) of normal rabbit IgG
(Merck Chemicals GmbH, Darmstadt, Germany).
Statistical analysis
All experiments were performed considering at least three biological
replicates. Unpaired t-tests were performed using GraphPad Prism Version
4.03 for Windows (GraphPad Software, La Jolla, CA, USA; www.graphpad.
com). Asterisks in ﬁgures summarise P-values (*Po0.05; **Po0.01;
***Po0.001; ****Po0.0001).
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